Erection
Treatment Review
Edition 01
October 2026
The wider options

Put other treatment categories on the discussion list

An online medication menu is one part of ED care. Ask what another approach would involve and why it is being considered.

Inside this review

Begin with the reason for a different approach

A clinician may consider another treatment category because of the assessment, unwanted effects, other medicines or a patient's preferences. Ask what issue the proposed approach is intended to address. The next step should have a clinical reason rather than simply being the next item in a commercial catalog.

NIDDK describes medical, sexual and mental-health history, physical examination and possible tests in ED diagnosis. That process can identify questions a remote medicine request cannot settle on its own. A broader assessment is not automatically a sign that an earlier treatment has failed or that every person needs the same specialist pathway. [Diagnosis]

Understand the category before comparing products

NIDDK's treatment overview includes medicines, counseling, vacuum devices and surgery among possible approaches. It also discusses medicines administered in ways other than oral tablets. Each category raises its own questions about suitability, training, risks, follow-up and personal preference. This guide does not rank those approaches for the reader. [Treatment overview]

For a device, ask who explains its use and limitations. For a procedure, ask about assessment, recovery, expected benefits and risks. For an injectable prescription, ask how instruction and urgent support are provided. Those discussions belong with the treating professional; this publication does not provide procedural or injection instructions.

Read a service's scope without inferring superiority

Henry Meds, for example, advertises injectable ED options as well as oral care. Its injection page describes Bimix, Trimix and Quadmix preparations. That establishes an advertised service category, not that an injection is better than a tablet for a particular person or that every reader can use the pathway. [Henry injectable care]

Where a preparation is compounded, FDA's distinction remains relevant: compounded drugs are not FDA-approved. Ask about the actual proposed medicine and evidence instead of transferring claims from an ingredient or another product. Our Henry profile keeps the service and price details separate from clinical conclusions. [FDA]

Include other support without assigning blame

NIDDK describes psychological factors among possible contributors and counseling as an option in relevant circumstances. That does not establish that a particular person's ED is purely psychological. Medical and emotional questions can both deserve attention, and a referral should explain what support is intended. [Contributors] [Care approaches]

Ask who coordinates the plan when several professionals are involved. The medicine-review guide helps gather shared information, and the service comparison helps examine advertised scope. A larger menu is useful to understand; it does not make the individual treatment decision.

Source record

Accessed October 6, 2026. Medical resources and labeling supply general context. Provider-owned pages establish advertised terms, not independently tested outcomes.

  1. NIDDK: Treatment for erectile dysfunctionFederal patient information
  2. NIDDK: Diagnosis of erectile dysfunctionFederal patient information
  3. NIDDK: Symptoms and causes of erectile dysfunctionFederal patient information
  4. Henry Meds: Injectable ED careProvider-owned treatment scope and starting offer
  5. FDA: Compounding questions and answersRegulatory explanation